CBD is not a scam in the sense that it’s a real compound with measurable biological activity, but the CBD market is riddled with problems that make it feel like one. Only about 31% of CBD products sold online are accurately labeled, the FDA still doesn’t regulate CBD as a supplement or food additive, and many of the health claims you see on packaging have little or no clinical evidence behind them. The compound itself has legitimate science supporting a narrow set of uses. The gap between what CBD can do and what companies say it can do is where the “scam” lives.
What CBD Actually Does in the Body
CBD interacts with your body’s endocannabinoid system, a network of receptors found in the brain and throughout your organs. Unlike THC, it doesn’t produce a high. It binds to cannabinoid receptors (CB1 and CB2) but also activates serotonin receptors, which play a role in mood and anxiety, and interacts with pain-signaling channels throughout the nervous system. This is real pharmacology, not placebo hand-waving.
The problem is that having a mechanism of action doesn’t mean a product works for everything stamped on its label. Aspirin interacts with real biological pathways too, but that doesn’t make it a cure for cancer. CBD’s biological activity is genuine but modest, and it varies dramatically depending on dose, delivery method, and what you’re trying to treat.
Where the Evidence Is Strongest
The clearest proof that CBD works comes from Epidiolex, the only FDA-approved CBD medication. It’s prescribed for severe childhood epilepsy disorders (Lennox-Gastaut syndrome and Dravet syndrome) at carefully controlled doses, and it went through the same rigorous clinical trial process as any other pharmaceutical. This isn’t a wellness product. It’s a prescription drug with documented side effects, drug interactions, and specific dosing protocols.
For anxiety, human trials have shown CBD can reduce symptoms in specific, controlled settings. Doses of 300 to 600 mg reduced anxiety scores during simulated public speaking tests in both healthy volunteers and people with social anxiety disorder. One study using 400 mg showed similar results during a brain-imaging procedure. These are real findings published in peer-reviewed journals.
But here’s the catch: those effective doses were 300 to 600 mg of pharmaceutical-grade CBD taken in a single dose. Most commercial CBD gummies and tinctures contain 10 to 50 mg per serving. That’s a fraction of what was used in the studies. And some trials found that CBD had no effect on baseline anxiety at all, only reducing anxiety that was experimentally induced. The picture is more complicated than “CBD helps anxiety.”
For chronic pain, a systematic review of 15 studies found pain reduction ranging from 42% to 66%, but many of those studies used CBD combined with THC, and the reviewers noted the evidence should be interpreted cautiously due to small sample sizes and inconsistent study designs.
Why So Little CBD Reaches Your System
One of the most underappreciated problems with CBD products is bioavailability, meaning how much of what you swallow actually enters your bloodstream. When you take CBD orally (gummies, capsules, oils you swallow), your body absorbs somewhere between 13% and 19% of it. The rest gets broken down in your gut and liver before it ever reaches circulation. Smoking or vaping CBD delivers about 31%, which is better but comes with its own risks.
So if you take a 25 mg CBD gummy, your body might absorb 3 to 5 mg. Compare that to the 300 to 600 mg doses that showed anxiety-reducing effects in clinical trials, and you can see the math doesn’t add up for most commercial products.
The Labeling Problem
Even if you’re buying a product with a reasonable dose on the label, you may not be getting what you paid for. A study published in JAMA tested 84 CBD products purchased online and found that only 31% were accurately labeled. About 43% contained more CBD than advertised, and 26% contained less. That last group is the real concern: if your product has significantly less CBD than the label claims, you’re paying for something that can’t possibly deliver the effect you’re expecting.
A larger study of 202 commercial CBD products found that lead was detected in 22% of products tested, with 3% exceeding regulatory safety thresholds. Pesticides showed up 55 times across 30 products. Full-spectrum CBD products contained pesticides at roughly double the rate of isolate products. Two broad-spectrum products that were supposed to be THC-free actually contained more than 0.3% THC, enough to potentially trigger a positive drug test.
The FDA’s Unusual Position
The FDA has concluded that CBD cannot legally be sold as a dietary supplement or added to food. This isn’t a technicality. It means that every CBD gummy, tincture, and capsule on store shelves exists in a regulatory gray zone. The FDA has stated that existing frameworks for foods and supplements “are not appropriate for cannabidiol” and has said it will work with Congress on new regulations.
In practice, this means no one is consistently verifying that CBD products contain what they claim, are free from contaminants, or are safe at the doses being sold. The industry is largely self-policing, which is why product quality varies so wildly.
Drug Interactions Are Real
One area where CBD is unambiguously not a scam is drug interactions. CBD inhibits several liver enzymes responsible for breaking down common medications. If you take CBD alongside antidepressants (SSRIs or tricyclics), antipsychotics, beta-blockers, opioids, or common pain relievers like naproxen or tramadol, CBD can cause those drugs to build up to higher-than-intended levels in your blood. This can amplify side effects or create dangerous interactions. Steroids like hydrocortisone and prednisolone are also affected. This is not a theoretical concern; it’s well-documented pharmacology.
How to Evaluate a CBD Product
If you decide to try CBD, the single most important thing you can do is look for a certificate of analysis (COA) from a third-party lab. A legitimate COA should include the product name and batch number, the cannabinoid profile showing exactly how much CBD (and THC) the product contains, contaminant testing results for heavy metals, pesticides, and microbial threats like E. coli and salmonella, and residual solvent testing for extracts and vape products. Every contaminant category should show a “PASS” status. If a company doesn’t make its COA available, or if the lab results don’t match the label claims, that’s a red flag.
Isolate products (pure CBD with no other cannabis compounds) tend to have lower contamination rates than full-spectrum products. They also won’t contain THC, which matters if you’re subject to drug testing.
The Bottom Line on Legitimacy
CBD is a real compound with real biological effects, and calling it a complete scam ignores the FDA-approved medication and the clinical trial data that exists. But the consumer CBD market has serious problems: most products are inaccurately labeled, poorly regulated, sold at doses far below what clinical research has tested, and marketed with health claims that outrun the evidence. You’re not being scammed by the molecule. You may be getting scammed by the product, the dose, or the promise on the label.